• Mashup Score: 0

    Edwina Brown joins Jonathan to discuss the adverse effects of dialysis on elderly and frail people, and peritoneal dialysis.

    Tweet Tweets with this article
    • On this week's EMJ Podcast, Edwina Brown @EdwinaBrown_PD joins us to discuss peritoneal dialysis, and how nephrologists can take a more person-centred approach to medical care. Listen now 👉 https://t.co/0JgPNwblvt #peritonealdialysis #haemodialysis #patientcare https://t.co/M3y0S7IdpL

  • Mashup Score: 70

    The SARS-CoV-2 variant of concern (VOC) B.1.1.529 omicron is now the predominant VOC in the UK.1 The burden of more than 30 mutations in omicron spike suggests at least a degree of vaccine evasion,2 and UK Health Security Agency estimates of vaccine efficacy against infection are reduced compared to delta.1 The critical question is how well existing vaccines will protect clinically extremely…

    Tweet Tweets with this article
    • In the context of #omicron, a critical question is how well vaccines will protect clinically extremely vulnerable groups against infection. Research letter: Omicron neutralising antibodies after COVID-19 vaccination in #haemodialysis patients. https://t.co/lvOdDJ7Gus

    • #Omicron neutralising antibodies after COVID-19 vaccination in #haemodialysis patients: a research letter from Edward J Carr & colleagues. https://t.co/lvOdDJ7Gus

  • Mashup Score: 3

    The SARS-CoV-2 variant of concern (VOC) B.1.1.529 omicron is now the predominant VOC in the UK.1 The burden of more than 30 mutations in omicron spike suggests at least a degree of vaccine evasion,2 and UK Health Security Agency estimates of vaccine efficacy against infection are reduced compared to delta.1 The critical question is how well existing vaccines will protect clinically extremely…

    Tweet Tweets with this article
    • In the context of #omicron, a critical question is how well existing vaccines will protect clinically extremely vulnerable groups against infection. A research letter reports on omicron neutralising antibodies after vaccination in #haemodialysis patients. https://t.co/SUTjaHxDER

  • Mashup Score: 0

    The SARS-CoV-2 variant of concern (VOC) B.1.1.529 omicron is now the predominant VOC in the UK.1 The burden of more than 30 mutations in omicron spike suggests at least a degree of vaccine evasion,2 and UK Health Security Agency estimates of vaccine efficacy against infection are reduced compared to delta.1 The critical question is how well existing vaccines will protect clinically extremely…

    Tweet Tweets with this article
    • Clinically extremely vulnerable groups & COVID-19 vaccines in the context of #omicron: a research letter reports on #omicron neutralising antibodies after vaccination in #haemodialysis patients. https://t.co/C30AlMu8rL

  • Mashup Score: 33

    Vaccination against COVID-19 induces highly protective immune responses in most people. As some countries switch from suppression to acceptance of transmission of SARS-CoV-2 within a largely vaccinated adult population, vulnerable patient groups that have not mounted adequate immune responses to vaccination might experience significant morbidity and mortality. There is an urgent need to identify…

    Tweet Tweets with this article
    • Neutralising antibodies after #COVID19 vaccination in UK #haemodialysis patients—Edward Carr and colleagues report interim analysis in a new research letter. @TheCrick https://t.co/6jxAu6PzRx

  • Mashup Score: 2

    Effective treatment of kidney failure depends on reliable vascular access; however, options for chronic vascular access for haemodialysis have remained unchanged for decades. This Review evaluates the key existing challenges in establishing and maintaining vascular access and describes novel and innovative technologies under development that address these issues.

    Tweet Tweets with this article
    • Innovations in graft and graft–catheter materials for vascular access in #haemodialysis. https://t.co/yfdfdOXkMk https://t.co/rfL6O6jZc5